ArticleAnalytical and bioanalytical chemistry2026
DDA/DIA mass spectrometry coupled with molecular networking and machine learning: high-coverage profiling of pyrrolizidine alkaloids.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- LC-HRMS and Molecular Networking for Non-Targeted Screening of Emerging Contaminants in Cosmetics: Workflow, Applications, and Regulatory Challenges.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Pyrrolizidine alkaloids (PAs) are naturally occurring toxic secondary metabolites found in plants. However, the identification of PAs often relies on commercially available standards, which are expensive and limited in availability. To overcome this limitation, we developed molecular networks (MNs) from both data-dependent acquisition (DDA) and data-independent acquisition (DIA) data, utilizing specialized platforms tailored for each data type. Three approaches were employed for compound annotation: comparison with reference standards, library-based screening, and the deduction of candidate compounds based on precursor and characteristic fragment ions. Through the analysis of ten distinct herb species, DDA and DIA data led to the detection of 152 and 78 PA-like compounds, respectively. Meanwhile, several previously unreported compounds were identified, including 63 compounds in DDA data and 28 compounds in DIA data. Furthermore, a retention time (RT) prediction model was constructed using machine learning (ML) to enhance the accuracy of compound annotation. The prediction model, trained on 27 PA standards, exhibited a maximum error of 0.76 min in the test set, with an overall error within 1.5 min. The results show that there are 52.0% and 62.8% compound errors within 1.5 min for DDA and DIA data in the experiment. These combined methods significantly expand the number of detected compounds and improve the accuracy of PA annotation.
Indexed as
Identifiers
42082669What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.